| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.500 | None | 0.969 | 18 | 0 | 1986 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.600 | None | 1.000 | 13 | 0 | 1996 | 2019 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.600 | None | 0.949 | 5 | 0 | 1990 | 2019 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
group | 0.060 | None | 1.000 | 4 | 0 | 2002 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2004 | 2008 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
group | 0.100 | None | 1.000 | 4 | 0 | 1995 | 2018 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
group | 0.050 | None | 1.000 | 2 | 0 | 1995 | 2019 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
intercellular adhesion molecule 1 | 0.364 | 0.962 | 3.5E-02 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 1993 | 2006 | ||||||||
|
Rac family small GTPase 1 | 0.429 | 0.962 | 0.76 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 2007 | 2018 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 2003 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.400 | None | 0.950 | 10 | 0 | 1999 | 2019 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
group | 0.080 | None | 1.000 | 5 | 0 | 2002 | 2019 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
group | 0.060 | None | 1.000 | 5 | 0 | 2004 | 2015 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
group | 0.040 | None | 1.000 | 3 | 0 | 1998 | 2005 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.400 | None | 0.971 | 3 | 0 | 1987 | 2018 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
group | 0.540 | None | 1.000 | 3 | 0 | 2005 | 2011 | ||||||||
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
group | 0.330 | None | 1.000 | 3 | 0 | 2005 | 2011 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2007 | 2008 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
group | 0.030 | None | 1.000 | 2 | 0 | 2005 | 2011 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
group | 0.030 | None | 1.000 | 2 | 0 | 2002 | 2007 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2008 | 2009 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
group | 0.360 | None | 0.857 | 2 | 0 | 2008 | 2019 | ||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2007 | 2007 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 |